Search by Drug Name or NDC

    NDC 70114-0220-02 YUSIMRY 40 mg/.8mL Details

    YUSIMRY 40 mg/.8mL

    YUSIMRY is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Coherus BioSciences Inc. The primary component is ADALIMUMAB.

    Product Information

    NDC 70114-0220
    Product ID 70114-220_02396ea7-3594-4b29-8f8e-7d187692161f
    Associated GPIs
    GCN Sequence Number 084535
    GCN Sequence Number Description adalimumab-aqvh PEN INJCTR 40MG/0.8ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 53867
    HICL Sequence Number 047742
    HICL Sequence Number Description ADALIMUMAB-AQVH
    Brand/Generic Brand
    Proprietary Name YUSIMRY
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab-aqvh
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 40
    Active Ingredient Units mg/.8mL
    Substance Name ADALIMUMAB
    Labeler Name Coherus BioSciences Inc
    Pharmaceutical Class Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761216
    Listing Certified Through 2024-12-31

    Package

    NDC 70114-0220-02 (70114022002)

    NDC Package Code 70114-220-02
    Billing NDC 70114022002
    Package 2 SYRINGE, GLASS in 1 CARTON (70114-220-02) / .8 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-07-01
    NDC Exclude Flag N
    Pricing Information N/A